Utilizing population-based clinical and administrative data to explore the relevance of frailty to cholinesterase inhibitor use and discontinuation at nursing home transition.
Introduction Cholinesterase inhibitors (ChEIs) are medications used to treat cognitive symptoms associated with Alzheimer’s disease. Previous studies examining the determinants of continued use or withdrawal of ChEIs during the transition into a nursing home have lacked detailed clinical information...
Main Authors: | Laura Maclagan, Colleen Maxwell, Jun Guan, Michael Campitelli, Nathan Herrmann, Kate Lapane, David Hogan, Joseph Amuah, Dallas Seitz, Sudeep Gill, Susan Bronskill |
---|---|
Format: | Article |
Language: | English |
Published: |
Swansea University
2018-08-01
|
Series: | International Journal of Population Data Science |
Online Access: | https://ijpds.org/article/view/655 |
Similar Items
-
Utilizing population-based clinical and administrative data to estimate the incremental healthcare costs of dementia and frailty among community-residing care recipients.
by: Luke Mondor, et al.
Published: (2018-08-01) -
Statin therapy and mortality among new long-term care residents in Ontario, Canada: the contribution of clinical assessment data to a population-based cohort study
by: Michael Campitelli, et al.
Published: (2017-04-01) -
Frailty, cognitive impairment, and depressive symptoms in Chinese older adults: an eight-year multi-trajectory analysis
by: Yiyang Yuan, et al.
Published: (2023-12-01) -
Cholinesterase research outreach project (CROP): point of care cholinesterase measurement in an Australian agricultural community
by: Jacqueline Cotton, et al.
Published: (2018-04-01) -
Pesticides and Cholinesterase
by: Frederick M. Fishel
Published: (2009-12-01)